Simian Foamy Virus Transmission to Humans

RecruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

November 1, 2010

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Simian Foamy Virus Infection (Disorder)
Interventions
DIAGNOSTIC_TEST

Simian foamy virus Infection

Plasma samples are tested for the presence of antibodies directed against foamy viruses by western blotting (WB). The BHK-21 cell line infected with a chimpanzee foamy virus is used as a source of viral antigen. Samples are considered to be positive if there is net reactivity against the GAG doublet (70 to 74 kD). High molecular weight DNA will be extracted, from either buffy coats, cell cultures, or both, for molecular biology studies. The presence and quality of the DNA will be verified by amplification of a fragment of the beta-globin gene. Two regions of foamy virus genomic DNA will be amplified by nested PCR, using generic amplimers, giving rise to fragments of the integrase gene (425 bp) and LTR (109 bp).

Trial Locations (1)

Unknown

RECRUITING

Centre Pasteur du CAmeroun, Yaoundé

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Institut Pasteur

INDUSTRY

NCT03225794 - Simian Foamy Virus Transmission to Humans | Biotech Hunter | Biotech Hunter